RSNA Conference Extension Page

Learn about our FDA-cleared and CE-marked clinical products through case studies presented by real users.

Click below to schedule a meeting with us at Booth 4542!

RSNA

Watch NeuroQuant case studies for the assessment of Alzheimer’s disease and Dementia

Dementia: Age-Related Atrophy Report

Watch OnQ Prostate: Multi-case study review demonstrating improved prostate cancer detection

OnQ Prostate

Quantitative MRI for Prostate Cancer Detection and Monitoring

Dr. Tyler Seibert MD, PhD of the University of California, San Diego will present data regarding the use of “Quantitative MRI for Prostate Cancer Detection and Monitoring” at this year’s Radiological Society of North America (RSNA) conference in Chicago.

The presentation will take place on Wednesday, December 1, 2021, at 2 p.m. in the AI Theater in the south hall of McCormick Place Convention Center.  

Read Dr. Seibert’s Bio

OnQ® Prostate

OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI), powered by AI, the software enables faster, more accurate PI-RADS scoring and improved inter-reader agreement. 

OnQ Prostate: Multi-case study review demonstrating improved prostate cancer detection

Dr. Schwartzberg, MD uses OnQ Prostate to assess clinically significant prostate cancer. He first reviews the standard T2 imaging series, diffusion-weighted imaging series, (DWI), and apparent diffusion coefficient (ADC) map, then reviews the RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI can increase conspicuity and how, in this case, informs his designation of the PI-RADS number.

OnQ Prostate
  • You can include your preferred date and time, or just ask your question here and we will respond to your email.

Contact Us

Would you prefer to add a date and time directly to a calendar? Click here to schedule a discovery meeting.